Other Issuances: OIG issues audit reports on oxaliplatin
Medicare Weekly Update, April 28, 2009
Want to receive articles like this one in your inbox? Subscribe to Medicare Weekly Update!
OIG issues review of oxaliplatin billing at Hilo Medical Center for CY 2004
On April 21, the OIG issued a review of oxaliplatin billing at Hilo Medical Center for CY 2004. The OIG found that Hilo billed Medicare for an incorrect number of service units and received overpayments totaling approximately $60,000.
View the OIG report.
OIG issues report on third-quarter 2008 ASP and AMP
On April 20, the OIG issued a review third-quarter 2008 average sales prices (ASP) and average manufacturer prices (AMP) and their impact on Medicare reimbursement for first quarter 2009.
View the OIG report.
Want to receive articles like this one in your inbox? Subscribe to Medicare Weekly Update!
Related Products
Most Popular
- Articles
-
- Q/A: Volume requirement for reporting hydration services
- HIPAA Q&A: Level of encryption needed for email
- Featured blog post: Nurses face felony charges after reporting physician to the Texas Medical Board
- Catch up on what's new with injections and infusions
- Identify potential Medicaid RAC target areas
- Capturing all necessary codes for IUD insertion and removal can be challenging
- Topic: CMS, OESS post new security compliance review information, checklist
- What does case-mix index mean to you?
- Q&A: Acute respiratory failure diagnosis does not require intubation
- OB services: Coding inside and outside of the package
- E-mailed
-
- Q/A: Volume requirement for reporting hydration services
- HIPAA Q&A: Level of encryption needed for email
- Featured blog post: Nurses face felony charges after reporting physician to the Texas Medical Board
- CMS has reformulated payments for some bilateral procedures
- Oxygen Cylinder Storage Requirements
- Q&A: Follow CMS' coding guidelines when using modifier -25
- Understand the spine to code back procedures correctly
- What does case-mix index mean to you?
- Catch up on what's new with injections and infusions
- New conflicts of interest create new challenges
- Searched
